Neoadjuvant combined modality therapy with weekly docetaxel and cisplatin, 5-fluorouracil continuous infusion and concurrent radiotherapy provides high pathological response rate in adenocarcinoma of the EGJ / De Manzoni, G; Pasini, F; Giacopuzzi, S; Zanoni, A; Pedrazzani, C; Minicozzi, A; Grandinetti, A. - STAMPA. - (2007). ( 7th IGCC San Paolo 9-12 Maggio 2007).
Neoadjuvant combined modality therapy with weekly docetaxel and cisplatin, 5-fluorouracil continuous infusion and concurrent radiotherapy provides high pathological response rate in adenocarcinoma of the EGJ
Pedrazzani C;
2007-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione
